Treatment of vascular graft infections in peripheral bypass surgery in the absence of endogenous material necessitates the use of infection-resistant materials. The present study showed promising results using a collagen-biosynthetic prosthesis. Due to a lack of long-term results, the graft should be used only after detailed informed consent is obtained from the patient. The expenses incurred by using the biosynthetic graft should be covered adequately by revenues from these patients.

No abstract

No abstract

Background: The LiMAx test can validly determine liver maximal capacity and has been successfully integrated in clinical management in liver surgery. However, no prospective randomized trials have been available to judge its actual clinical impact. Methods: A randomized controlled trial (RCT) was conducted from January 2013 to September 2015 in six recruiting hospitals. Patients prior open liver resection of at least one segment were included. Patients were randomly assigned to LiMAx group (pre-, and postoperative LiMAx test) or control group (standard-of-care). Stable patients with sufficient residual liver function (LiMAx >150 mg/kg/h) were directly transferred to general

No abstract